Ardena has US-Präsenz and Unterzeichnet Vereinbarung zur Akquisition a high modern recuperation sanlage for Arzneimittel von Catalent

^GHENT, Belgium, October 15, 2024 (GLOBE NEWSWIRE) — Ardena, auf

Special equipment for the removal and recovery of pharmaceutical products

(Contract Development and Manufacturing Organization, CDMO) with GMP Standorten

in Belgium, Spain, the Netherlands and Sweden, with the Unterzeichnung

a definitive Vereinbarung zur Übernahme an Advanced Drug Product

Catalent production facility in Somerset, New Jersey, available. Die

The description is important for the Kompetenzen von Ardena in the Recovery

oral examinations for spare clinical phases and small, troubled souls

More information and internal strategy are a global issue

CDMO, the integrated solution for the pharmaceutical industry

Entwicklungszyklus anbietet, ausbauen.

Der von der FDA-zugelassene Standort in Somerset beschäftigt beef 200

qualified Wissenschaftler and Fachexperten and is a Zentrum der Kompetenz

for the high quality of the Darreichungsformen, a best hand

Expertise von Ardena im Reich der Verabreichten Formulierungen zu

completed. The takeover was managed smoothly by Ardena

seine bioanalytical service leistungen in de USA are erweitern und einen

Waiting hours can be operated by the standard increasing Nachfrage

after additional services for the maintenance work

all. These advanced recovery technologies and analytical experts

the pitches are integrated into the Vorgehensweise von Ardena, converted

Lösungen für Pharma- en Biotechnologiekunde on both Seiten des Atlantiks

anzubites.

?Der heutige Tag marks one of the most important Meilenstein in the international

Wachstumsstrategie von Ardena”, explains Jeremy Trochu, Chief Executive Officer

from Ardena. ?Wir our friends, our talent is clear and

operative team in Somerset in the Family of Ardena will come back. Thats

Engagement-dies Teams for an excellent service deck is perfect

with our Grundwerten: Exzellenz, Zuverlässigkeit, Sorgfalt and Integrität.

Gemeinsam will be treated with more biopharmaceutical products, the other ones

Spitze der Innovatie Stehen, een patientweltweit life-changing therapy

zur Verfügung zu set.”

?This expansion in North America is for the Ardena through separate companies,

we would like to know more about global production of wool”, so Trochu. ?Durch

de Erweiterung fortschrittlicher Technology met der Heiß-Schmelz-Extrusion

we are still not sure about the solutions for improving the bioefficiency,

especially with our expertise in innovative nanomedical development

Drug delivery system. No more can be done with those investments

Geschäftstätigkeit ausweiten unser Angebot erweitern, een unseren schnell

Waiting internationals can serve better customers.”

GHO Capital, Ardena’s private equity partner, is a major war company

Realization of the best results, the transatlantic expansion of

Ardena weiter zu beschleunigen. The Partner of GHO Capital commented: ?Wir

Friends, that this bedeuting Übernahme sister has come. Be damned

those technological and market-relevant Kompetenzen von Ardena

Schlüsselregionen are equipped and equipped for a night’s sleep

Wertschöpfung und de langfristigen Erfolg unter der Führung von Herrn Trochu

positioned.”

The Abschluss der Transaction will take place before Anfang 2025, before it is executed

take care of general and other Abschlussbedingungen.

Hints for editors:

Uber Ardena

Ardena is a cursory lung and lung recovery lung surgery for

the Arzneimittelentwicklung new, innovative and complex Molecule. Ardennes

it’s so you can focus on the time and therapy you need

Generation more likely to encounter problems and the patients they bring.

Ardena unterstützt Biopharmazieunternehmen bij de Erforschung und Entwicklung

von Arzneimitteln, an effective and regulatory compliant Wirkstoffe and

Arzneiproducts für Clinical Studies in entwickeln. Dazu bietet Ardena

integrated solutions and, Darunter Festkörperchemical, API- und

Nanomedizinentwicklung und -Herstellung, Formulierungsentwicklung, en

-Herstellung von Arzneimitteln ensures bioanalytical and CMC regulatory

Services.

You will find a photo of this person

under http://www.globenewswire.com/NewsRoom/AttachmentNg/1be1c9c2-0305-4238-

b377-4e11a264d6d8

°